Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

GOCO vs ABSI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ABSI Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–1 Matrix Metrics)

ABSI Overall Winner 6-Pillar Tally: GOCO 2 – 3 ABSI (1 Tie) Matrix Metrics: GOCO 1 – 7 ABSI

As of Nov 17, 2026, Absci Corporation (ABSI) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). GOCO carries a Unified Composite Score of 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin), whereas ABSI carries 50.8/100 (HOLD) at $7.55 (N/M Forward P/E, -9108.3% operating margin).

  • Technical & Structure Timing Caution: GOCO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9); meanwhile ABSI is in a Breakdown options structure phase (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GOCO vs ABSI
GOCO NASDAQ
GoHealth, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$0.30
+5.14% 1D
Market Cap $8.5M
TTM Revenue $153M
Forward P/E N/M
Beta / 30D Vol 2.15β · 201% Vol
Unified Composite Score
42.9 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 48.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -32.2%), weak momentum, RSI 24
RSI-14: 23.9 · SMA20: $0.59 · SMA50: $0.88
ABSI NASDAQ Head-to-Head Winner
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.55
+1.0% 1D
Market Cap $1.5B
TTM Revenue $1.5M
Forward P/E N/M
Beta / 30D Vol 3.31β · 126% Vol
Unified Composite Score
50.8 / 100 HOLD
Tech 50.0 Fund 56.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.4 · SMA20: $9.85 · SMA50: $9.60

6-Pillar Scorecard Institutional Category Breakdown (GOCO 2 – 3 ABSI)

Columns: Metric · GOCO · ABSI
1. Valuation Multiples GOCO
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.1x N/M
2. Growth & Scale ABSI
Revenue Growth (YoY) -94.6% -19.6%
Earnings Growth (YoY) +424.1% +0.0%
TTM Revenue (USD) $153M $1.5M
Market Cap $8.5M $1.5B
3. Profitability & Quality GOCO
Gross Margin 57.3% N/A
Operating Margin -292.0% -9108.3%
Net Profit Margin -189.7% 0.0%
Return on Equity (ROE) -289.9% -58.6%
4. Balance Sheet & Cash Flow ABSI
Cash Generation (TTM) -$148M EBITDA -$112M
Cash Flow Margin -96.9% EBITDA Mgn N/A
Net Cash / Leverage $0.13 Book/Sh · -289.9% ROE $10M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABSI
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 169.1% (15th %ile)
Put/Call OI Skew N/A 1.21x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance Brokers Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GOCO (1) vs ABSI (7)
Institutional Metric GOCO ABSI Criterion Row Edge
Market Capitalization
Scale
$8.5M $1.5B Larger Scale ABSI
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-94.6% -19.6% Higher Growth ABSI
Operating Margin (TTM)
Profitability
-292.0% -9108.3% Higher Margin GOCO
Net Profit Margin
Profitability
-189.7% 0.0% Higher Margin ABSI
Return on Equity (ROE)
Capital Efficiency
-289.9% -58.6% Higher ROE ABSI
52-Week Range Position
Momentum
0% ($0–$7) 52% ($2–$13) Stronger Trend ABSI
Beta / 30D Volatility
Risk Regime
2.15β · 201% Vol 3.31β · 126% Vol Lower Realized Risk ABSI
Unified Institutional Score
Composite Signal
42.9 / 100 (HOLD) 50.8 / 100 (HOLD) Higher Composite ABSI
Trailing 12M Revenue (USD)
Operating Scale
$153M $1.5M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
57.3% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$148M EBITDA ($0.13 Book/Sh · -289.9% ROE) -$112M ($10M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABSI +95.92 pp
GOCO: -64.69% · ABSI: +31.23%
3M Horizon ABSI +272.32 pp
GOCO: -81.52% · ABSI: +190.8%
6M Horizon ABSI +179.88 pp
GOCO: -90.56% · ABSI: +89.32%
1Y Horizon ABSI +245.77 pp
GOCO: -87.97% · ABSI: +157.8%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GOCO vs ABSI. Trailing 12-month operating profitability (GOCO -292.0% vs ABSI -9108.3%) and valuation multiples (GOCO N/M vs ABSI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GOCO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$153M
Gross Margin57.3%
Op. Margin-292.0%
ROE / Fwd P/E-289.9% · N/M
ABSI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.5M
Gross MarginN/A
Op. Margin-9108.3%
ROE / Fwd P/E-58.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GOCO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GOCO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABSI BREAKDOWN
98d in phase · OBV NEUTRAL
Current IV 169.1%
IV Percentile 15th %ile
Put/Call OI Skew 1.21x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABSI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GOCO Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $8.5M market capitalization and -292.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ABSI Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.5B market capitalization and -9108.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ GOCO vs ABSI Key Questions & Quantitative Answers

As of Nov 17, 2026, Absci Corporation (ABSI) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). GOCO carries a Unified Composite Score of 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin), whereas ABSI carries 50.8/100 (HOLD) at $7.55 (N/M Forward P/E, -9108.3% operating margin). Technical & Structure Timing Caution: GOCO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9); meanwhile ABSI is in a Breakdown options structure phase (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ABSI leads the Growth & Scale pillar: GOCO posts -94.6% YoY revenue growth and +424.1% YoY earnings growth on $153M TTM revenue (57.3% gross margin, -292.0% operating margin), compared with ABSI at -19.6% YoY revenue growth and +0.0% YoY earnings growth on $1.5M TTM revenue (N/A gross margin, -9108.3% operating margin). On trailing 12-month operating scale, GOCO generates $153M in USD-normalized revenue versus $1.5M for ABSI. In operating R&D and SG&A reinvestment, GOCO deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABSI.

GOCO screens cheaper on headline valuation multiples. GOCO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-96.9% EBITDA margin), whereas ABSI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GOCO (-289.9% ROE) versus ABSI (-58.6% ROE) capital efficiency.

In options market volatility and institutional positioning, GOCO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.15β · 201% Vol realized risk). By comparison, ABSI carries 169.1% implied volatility (15th %ile, Compressed (<25th %ile)), a 1.21x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.31β · 126% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.